期刊文献+

肿瘤最大径对T4a期胃癌患者预后的影响 被引量:6

The prognostic analysis of tumor size in T4a stage gastric cancer
原文传递
导出
摘要 目的评价肿瘤最大径对T4a期胃癌患者预后的影响。方法Kaplan—Meier生存分析筛选T4a期胃癌肿瘤最大径的最佳截点值,并据此将患者分为2组。比较2组患者的临床病理因素,对T4a期胃癌进行单因素和多因素分析,并对预后独立影响因素进行分层分析。结果T4a期胃癌肿瘤最大径最佳截点值为8ClTI。2组患者的肿瘤部位(x2=15.695)、分化类型(X2=4.393)、大体形态(x2=5.629)和早期复发(x2=4.292)差异有统计学意义(P〈0.05)。单因素分析显示年龄(x2=4.463)、肿瘤最大径(x2=9.057)、Borrmann分型()(2=6.679),分化类型(x2=5.122)、肿瘤部位(x2=8.707)和N分期(x2=132.954)与T4a期胃癌预后相关(P〈0.05);多因素分析显示肿瘤最大径(HR=1.339),分化类型(HR=1_169)和N分期(HR=1.876)为T4a期胃癌预后独立影响因素(P〈0.05)。进一步按肿瘤最大径分层分析,N分期(HR=2.014)和分化类型(HR=1.192)是最大径〈8cm组T4a期胃癌预后独立影响因素(P〈0.05),N分期(HR=1.876)是最大径≥8cm组T4a期胃癌预后的独立影响因素(P=0.000)。预后独立影响因素分层分析显示,无淋巴结转移或低分化的T4a期胃癌,≥8cnl组的5年生存率明显低于〈8cm组(HR=0.182、0.653,P〈0.01)。结论肿瘤大小截点值为8Cm时,肿瘤最大径是影响T4a期胃癌预后的独立影响因素,可显著影响无淋巴结转移或低分化胃癌患者的预后。 Objective To investigate the impact of tumor size in the prognosis of T4a stage gastric cancer. Methods The best cut-off point depending on tumor size was selected by Kaplan-Meier. Compare elinicl6pathological characteristics between small size gastric cancer (SSG) and large size gastric cancer (LSG). Univariate analysis was done by Log-rank test and multivariate analysis was performed using the Cox proportional hazard regression model. The independent prognostic factors of patients were performed subgroup analysis. Results Eight eentimetre was the optimal cut-off of tumor size for T4a stage gastric cancer. There were significantly differences between SSG and LSG in tumor location ( X2 = 15. 695 ), histological grade (X2 = 4. 393), macroscopic type (X2 = 5. 629) and early recurrence (X2 = 4. 292 ). Univariate analysis showed age ( X2 = 4. 463 ), tumor size ( X2= 9. 057 ), macroscopic type ( X2 = 6. 679 ), histological grade (X2= 5. 122), location of tumor (X2 = 8. 707) and N stage (X2 = 132. 954) are related to survival (P〈0. 05). Among them, tumor size (HR = 1. 339), histological grade (HR = 1. 169) and N stage (HR = 1. 876) were independent risk factor for survival (P =0.05). For SSG, N stage (HR =2. 014) and histological grade (HR = 1. 192) were independent risk factor for survival (P = 0. 05 ) , and for LSG, N stage (HR= 1. 876 ) was independent risk factor for survival (P = 0. 000 ). Further stratified analysis indicated that the 5-year survival rate of LSG is significantly lower than that of SSG in T4a stage patients of gastric cancer without lymph nodes metastasis or poorly differentiated (HR = 0. 182 and O. 653, P 〈 0. 01 ). Conclusions Tumor size is an independent prognostic factor in patients of T4a stage gastric cancer. Tumor size cut-off point of 8 cm can exert significant impact on the prognosis of T4a stage gastric cancer without lymph nodes metastasis or poorly differentiated.
出处 《中华外科杂志》 CAS CSCD 北大核心 2013年第3期230-234,共5页 Chinese Journal of Surgery
基金 国家重点基础研究发展计划(973计划)资助项目(2010CB529301)
关键词 胃肿瘤 肿瘤分期 预后 Stomach neoplasms Neoplasm staging Prognosis
  • 相关文献

参考文献14

  • 1Edge SB, Byrd DR. AJCC cancer staging handbook: from the AJCC cancer staging manual. 7th ed. New York: Springer, 2009: 143-154.
  • 2Liu X, Xu Y, Long Z, et al. Prognostic significance of tumor size in T3 gastric cancer. Ann Surg Oncol, 2009,16:1875-1882.
  • 3Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 ( ver. 3 ) Gastric Cancer, 2011,14: 113-123.
  • 4Dang J, Liang H, Wang D, et al. Enhancement the prediction of postoperative survival in gastric cancer by combining the negative lymph node count with ratio between positive and examined lymph nodes . Ann Surg Oncol, 2010,17 : 1043-1051.
  • 5Adachi Y, Oshiro T, Mori M, et al. Tumor size as a simple prognostic indicator for gastric carcinoma. Ann Surg Oncol, 1997, 4 : 137-140.
  • 6Wang X, Wan F, Pan J, et al. Tumor size: a non-neglectable independent prognostic factor for gastric cancer. J Surg Oncol, 2008,97:236-240.
  • 7Hyung WJ, Noh SH, Yoo CH, et al. Prognostic significance of metastatic lymph node ratio in 33 gastric cancer. World J Surg, 2002,26:323-329.
  • 8池桢,黄昌明,郑朝辉,李平,谢建伟,王家镔,林建贤.肿瘤大小对T3期胃癌患者预后的影响[J].中华胃肠外科杂志,2011,14(2):114-116. 被引量:8
  • 9Yokota T, Ishiyama S, Saito T, et al, Is tumor size a prognostic indicator for gastric carcinoma?. Anticancer Res, 2002, 22:3673- 3677.
  • 10Saito H, Osaki T, Murakami D, et al. Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer. Am J Surg, 2006,192:296-300.

二级参考文献12

  • 1Shiraishi N,Sato K,Yasuda K,et al.Multivariate prognostic study on large gastric cancer.J Surg Oncol,2007,96(1):14-18.
  • 2Xu CY,Shen JG,Shen JY,et al.Ulcer size as a novel indicator marker is correlated with prognosis of ulcerative gastric cancer.Dig Surg,2009,26(4):312-316.
  • 3Wang X,Wan F,Pan J,et al.Tumor size:a non-neglectable independent prognostic factor for gastric cancer.J Surg Oncol,2008,97 (3):236-240.
  • 4Jun KH,Jung H,Back JM,et al.Does tumor size have an impact on gastric cancer? A single institute experience.Langenbecks Arch Surg,2009,394 (4):631-635.
  • 5Liu X,Xu Y,Long Z,et al.Prognostic significance of tumor size in T3 gastric cancer.Ann Surg Oncol,2009,16 (7):1875-1882.
  • 6Hyung WJ,Noh SH,Yoo CH,et al.Prognostic significance of metastatic lymph node ratio in T3 gastric cancer.World J Surg,2002,26(3):323-329.
  • 7Saito H,Osaki T,Murakami D,et al.Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer.Am J Surg,2006,192(3):296-300.
  • 8Kunisaki C,Makino H,Takagawa R,et al.Tumor diameter as a prognostic factor in patients with gastric cancer.Ann Surg Oncol,2008,15(7):1959-1967.
  • 9Li C,Oh SJ,Kim S,et al.Risk factors of survival and surgical treatment for advanced gastric cancer with large tumor size.J Gastrointest Surg,2009,13 (5):881-885.
  • 10Kobayashi O,Tsuburaya A,Yoshikawa T,et al.The efficacy of gastrectomy for large gastric cancer.Int J Clin Oncol,2006,11(1):44-50.

共引文献7

同被引文献45

  • 1Ke Chen,Xiao-Wu Xu,Ren-Chao Zhang,Yu Pan,Di Wu,Yi-Ping Mou.Systematic review and meta-analysis of laparoscopy-assisted and open total gastrectomy for gastric cancer[J].World Journal of Gastroenterology,2013,19(32):5365-5376. 被引量:23
  • 2于俊秀,吴育连,杨立涛.淋巴结转移率评估T_3期胃癌病人预后的价值[J].中华医学杂志,2005,85(13):922-925. 被引量:12
  • 3Martin L,Lagergren P.Long-term weight change after oesophageal cancer surgery[J].Br J Surg,2009,96(11):1308-1314.
  • 4Edge SB,Compton CC.The American Joint Committee on Cancer:the 7th edition of the AJCC cancer staging manual and the future of TNM[J].Ann Surg Oncol,2010,17(6):1471-1474.
  • 5Birks S,Peeters A,Backholer K,et al.A systematic review of the impact of weight loss on cancer incidence and mortality[J].Obes Rev,2012,13 (10):868-891.
  • 6Tisdale MJ.Mechanisms of cancer cachexia[J].Physiol Rev,2009,89(2):381-410.
  • 7O'Gormamn P,McMillan DC,McArdle CS.Impact of weight loss,appetite,and the inflammatory response on quality of life in gastrointestinal cancer patients[J].Nutr Cancer,1998,32(2):76-80.
  • 8van der Schaaf MK,Tilanus HW,van Lanschot JJ.The influence of preoperative weight loss on the postoperative course after esophageal cancer resection[J].J Thorac Cardiovasc Surg,2014,147 (1):490-495.
  • 9Scott HR,McMillan DC,Brown D J,et al.A prospective study of the impact of weight loss and the systemic inflammatory response on quality of life in patients with inoperable non-small cell lung cancer[J].Lung Cancer,2003,40 (3):295-299.
  • 10Dewys WD,Begg C,Lavin PT,et al.Prognostic effect of weight loss prior to chemotherapy in cancer patients.Eastern Cooperative Oncology Group[J].Am J Med,1980,69 (4):491-497.

引证文献6

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部